Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic factors in patients with uterine sarcoma: the SARCUT study.
Zapardiel I, Gracia Segovia M, Macuks R, Mancari R, Achimas-Cadariu P, Corrado G, Bartusevicius A, Sukhin V, Muruzabal JC, Coronado Martín PJ, Gardella B, Piek JM, Concin N, Arab C, Papatheodorou D, Polterauer S, Iacoponi S, Nieto T, Lopez-Sanclemente MC, Trukhan H, Gil MM, Bakinovskaya I, Dalamanava A, Cucurull M, Rovski D, Baquedano L, Chiva L, Mardas M, Mavrichev SA, Klat J, Lopez de la Manzanara CA, Yildirim Y; SARCUT Study Group. Zapardiel I, et al. Among authors: muruzabal jc. Int J Gynecol Cancer. 2023 Jun 5;33(6):897-904. doi: 10.1136/ijgc-2022-004204. Int J Gynecol Cancer. 2023. PMID: 37192761
Scalp recurrence of uterine leiomyosarcoma.
Veiga N, Muruzábal JC. Veiga N, et al. Among authors: muruzabal jc. Int J Gynecol Cancer. 2023 Oct 2;33(10):1666. doi: 10.1136/ijgc-2023-004522. Int J Gynecol Cancer. 2023. PMID: 37666528 No abstract available.
Oncological outcomes of intraperitoneal chemotherapy in advanced ovarian cancer: BRCA mutation role.
Padilla-Iserte P, Iváñez M, Muruzabal JC, Navarro R, Díaz-Feijoo B, Iacoponi S, García-Pineda V, Díaz C, Utrilla-Layna J, Gil-Moreno A, Serra A, Gilabert-Estellés J, Martínez Canto C, Tejerizo Á, Lago V, Cárdenas-Rebollo JM, Domingo S; SEGO Spain-GOG Group. Padilla-Iserte P, et al. Among authors: muruzabal jc. Eur J Surg Oncol. 2024 Apr;50(4):108263. doi: 10.1016/j.ejso.2024.108263. Epub 2024 Mar 9. Eur J Surg Oncol. 2024. PMID: 38492526
Lymphovascular Space Invasion in Early-Stage Endometrial Cancer (LySEC): Patterns of Recurrence and Predictors. A Multicentre Retrospective Cohort Study of the Spain Gynecologic Oncology Group.
Oliver-Perez MR, Padilla-Iserte P, Arencibia-Sanchez O, Martin-Arriscado C, Muruzabal JC, Diaz-Feijóo B, Cabrera S, Coronado P, Martín-Salamanca MB, Pantoja-Garrido M, Marcos-Sanmartin J, Cabezas-López E, Lorenzo C, Beric D, Rodriguez-Hernandez JR, Roldan-Rivas F, Gilabert-Estelles J, Sanchez L, Laseca-Modrego M, Tauste-Rubio C, Gil-Ibañez B, Tejerizo-Garcia A, On Behalf Of The Spain-Gog Group. Oliver-Perez MR, et al. Among authors: muruzabal jc. Cancers (Basel). 2023 May 4;15(9):2612. doi: 10.3390/cancers15092612. Cancers (Basel). 2023. PMID: 37174081 Free PMC article.
Endometrial cancer: predictors and oncological safety of tumor tissue manipulation.
Quintana-Bertó R, Padilla-Iserte P, Lago V, Tauste C, Díaz-Feijoo B, Cabrera S, Oliver-Pérez R, Coronado PJ, Martín-Salamanca MB, Pantoja-Garrido M, Marcos-Sanmartin J, Cazorla E, Lorenzo C, Rodríguez-Hernández JR, Roldán-Rivas F, Gilabert-Estellés J, Muruzábal JC, Cañada A, Domingo S; SEGO Spain-GOG Group. Quintana-Bertó R, et al. Among authors: muruzabal jc. Clin Transl Oncol. 2024 May;26(5):1098-1105. doi: 10.1007/s12094-023-03310-6. Epub 2023 Sep 5. Clin Transl Oncol. 2024. PMID: 37668932
Neoadjuvant Chemotherapy plus Interval Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy (NIHIPEC) in the Treatment of Advanced Ovarian Cancer: A Multicentric Propensity Score Study.
Llueca A, Ibañez MV, Cascales P, Gil-Moreno A, Bebia V, Ponce J, Fernandez S, Arjona-Sanchez A, Muruzabal JC, Veiga N, Diaz-Feijoo B, Celada C, Gilabert-Estelles J, Aghababyan C, Lacueva J, Calero A, Segura JJ, Maiocchi K, Llorca S, Villarin A, Climent MT, Delgado K, Serra A, Gomez-Quiles L, Llueca M, On Behalf Of Spain Gog And Gecop Working Group. Llueca A, et al. Among authors: muruzabal jc. Cancers (Basel). 2023 Aug 26;15(17):4271. doi: 10.3390/cancers15174271. Cancers (Basel). 2023. PMID: 37686547 Free PMC article.
Effectiveness of Nirsevimab Immunoprophylaxis Administered at Birth to Prevent Infant Hospitalisation for Respiratory Syncytial Virus Infection: A Population-Based Cohort Study.
Ezpeleta G, Navascués A, Viguria N, Herranz-Aguirre M, Juan Belloc SE, Gimeno Ballester J, Muruzábal JC, García-Cenoz M, Trobajo-Sanmartín C, Echeverria A, Martínez-Baz I, Vera-Punzano N, Casado I, López-Mendoza H, Ezpeleta C, Castilla J. Ezpeleta G, et al. Among authors: muruzabal jc. Vaccines (Basel). 2024 Apr 4;12(4):383. doi: 10.3390/vaccines12040383. Vaccines (Basel). 2024. PMID: 38675765 Free PMC article.
24 results